465 related articles for article (PubMed ID: 9002767)
21. Long-term survival of atypical bronchial carcinoids with liver metastases, treated with octreotide.
Filosso PL; Ruffini E; Oliaro A; Papalia E; Donati G; Rena O
Eur J Cardiothorac Surg; 2002 May; 21(5):913-7. PubMed ID: 12062286
[TBL] [Abstract][Full Text] [Related]
22. [Somatostatin receptor-based imaging and therapy of digestive endocrine tumors].
Illouz F; Sadoul JL; Rohmer V
Ann Endocrinol (Paris); 2010 Sep; 71 Suppl 1():S3-12. PubMed ID: 21237328
[TBL] [Abstract][Full Text] [Related]
23. Is there a therapeutic role for octreotide in patients with ectopic Cushing's syndrome?
Uwaifo GI; Koch CA; Hirshberg B; Chen CC; Hartzband P; Nieman LK; Pacak K
J Endocrinol Invest; 2003 Aug; 26(8):710-7. PubMed ID: 14669823
[TBL] [Abstract][Full Text] [Related]
24. [The role of somatostatin analogues in the treatment of hypophyseal adenomas].
Losa M; Mortini P; Giovanelli M
Minerva Endocrinol; 2003 Mar; 28(1):39-51. PubMed ID: 12621362
[TBL] [Abstract][Full Text] [Related]
25. Somatostatin receptor scintigraphy in gastrinomas.
Jensen RT; Gibril F
Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S179-85. PubMed ID: 10604126
[TBL] [Abstract][Full Text] [Related]
26. Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: bone scintigraphy compared with somatostatin receptor scintigraphy.
Lebtahi R; Cadiot G; Delahaye N; Genin R; Daou D; Peker MC; Chosidow D; Faraggi M; Mignon M; Le Guludec D
J Nucl Med; 1999 Oct; 40(10):1602-8. PubMed ID: 10520698
[TBL] [Abstract][Full Text] [Related]
27. MEN 1 and 2: the role of diagnostic imaging.
Gollini P; Cataldi A; Fava C
Radiol Med; 2004; 107(1-2):78-87. PubMed ID: 15031699
[TBL] [Abstract][Full Text] [Related]
28. Pituitary adenomas: the role of 111In-DTPA-octreotide SPET in the detection of minimal post-surgical residues.
Lauriero F; Pierangeli E; Rubini G; Resta M; D'Addabbo A
Nucl Med Commun; 1998 Dec; 19(12):1127-34. PubMed ID: 9885802
[TBL] [Abstract][Full Text] [Related]
29. The pituitary uptake of (111)In-DTPA-D-Phe1-octreotide in the normal pituitary and in pituitary adenomas.
Colao A; Lastoria S; Ferone D; Varrella P; Marzullo P; Pivonello R; Cerbone G; Acampa W; Salvatore M; Lombardi G
J Endocrinol Invest; 1999 Mar; 22(3):176-83. PubMed ID: 10219884
[TBL] [Abstract][Full Text] [Related]
30. Indium-111-Octreotide scintigraphy in differentiated thyroid carcinoma metastases that do not respond to treatment with high-dose I-131.
Stokkel MP; Reigman HI; Verkooijen RB; Smit JW
J Cancer Res Clin Oncol; 2003 May; 129(5):287-94. PubMed ID: 12750997
[TBL] [Abstract][Full Text] [Related]
31. The radioguided 111In-pentetreotide surgery in the management of ACTH-secreting bronchial carcinoid.
Porziella V; Cesario A; Lococo F; Cafarotti S; Margaritora S; D'Errico G; Granone P
Eur Rev Med Pharmacol Sci; 2011 Jun; 15(6):587-91. PubMed ID: 21796863
[TBL] [Abstract][Full Text] [Related]
32. Incremental diagnostic value and impact on patient management of somatostatin receptor scintigraphy with indium-111-pentetreotide in gastroenteropancreatic neuroendocrine tumors.
Usmani S; Khan HA; Abdulla M; Ahmed N; abu Huda F; Marafi F; al Kandari F; al Mohannadi S; al Nafisi N
Med Princ Pract; 2011; 20(4):356-61. PubMed ID: 21576997
[TBL] [Abstract][Full Text] [Related]
33. ECTOPIC CUSHING SYNDROME: A 10-YEAR EXPERIENCE FROM A TERTIARY CARE CENTER IN SOUTHERN INDIA.
Sathyakumar S; Paul TV; Asha HS; Gnanamuthu BR; Paul MJ; Abraham DT; Rajaratnam S; Thomas N
Endocr Pract; 2017 Aug; 23(8):907-914. PubMed ID: 28614007
[TBL] [Abstract][Full Text] [Related]
34. Octreoscan in patients with bronchial carcinoid tumours.
Granberg D; Sundin A; Janson ET; Oberg K; Skogseid B; Westlin JE
Clin Endocrinol (Oxf); 2003 Dec; 59(6):793-9. PubMed ID: 14974924
[TBL] [Abstract][Full Text] [Related]
35. [Isotopic scan with somatostatin receptors in a case of recurrent carcinoid tumor. Relevance of tomographic detection].
Bernà Roqueta L; Martín Marimón JC; Martín Martínez J
Rev Esp Med Nucl; 2002 Apr; 21(2):123-4. PubMed ID: 11879622
[No Abstract] [Full Text] [Related]
36. Recurrent ectopic adrenocorticotropic hormone producing thymic carcinoid detected with octreotide imaging.
Silva F; Vázquez-Sellés J; Aguilö F; Vázquez G; Flores C
Clin Nucl Med; 1999 Feb; 24(2):109-10. PubMed ID: 9988068
[TBL] [Abstract][Full Text] [Related]
37. [Cushing's syndrome secondary to bronchial carcinoid tumor: contribution of gammagraphy with 111In-DTPA octreotide in the localization diagnosis].
Peña González E; Lampreave Márquez JL; León Atance P; Moreno Esteban B; Bittini Copano A; Folqué Gómez E
An Med Interna; 1999 Nov; 16(11):577-9. PubMed ID: 10637999
[TBL] [Abstract][Full Text] [Related]
38. Octreotide-sensitive ectopic ACTH production by islet cell carcinoma with multiple liver metastases.
Doi M; Imai T; Shichiri M; Tateno T; Fukai N; Ozawa N; Sato R; Teramoto K; Hirata Y
Endocr J; 2003 Apr; 50(2):135-43. PubMed ID: 12803233
[TBL] [Abstract][Full Text] [Related]
39. The incidental discovery of follicular thyroid cancer with in-111 pentetreotide scintigraphy in a patient with carcinoid tumor of the lung.
Villa G; Ratto GB; Carletto M; Rouhanifar H; Piccardo A; Tommasi L; Altrinetti V; Mereu C; Mariani G
Clin Nucl Med; 2003 Jan; 28(1):45-6. PubMed ID: 12493962
[No Abstract] [Full Text] [Related]
40. In-111 octreotide scan in a case of a neuroendocrine tumor of unknown origin.
Fuster D; Navasa M; Pons F; Vidal-Sicart S; Mateos JJ; Lomeña F; Rodes J; Herranz R
Clin Nucl Med; 1999 Dec; 24(12):955-8. PubMed ID: 10595476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]